**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 142-26-7 |N-Acetylethanolamine | 100 | 205-530-8 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XI
Risk Phrases: 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.Hygroscopic (absorbs
moisture from the air).
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause methemoglobinemia, cyanosis (bluish
discoloration of skin due to deficient oxygenation of the blood),
convulsions, and death.
Inhalation:
Causes respiratory tract irritation. May cause methemoglobinemia,
cyanosis (bluish discoloration of skin due to deficient oxygenation
of the blood), convulsions, tachycardia, dyspnea (labored
breathing), and death. Can produce delayed pulmonary edema.
Chronic:
May cause methemoglobinemia, which is characterized by
chocolate-brown colored blood, headache, weakness, dizziness, breath
shortness, cyanosis (bluish skin due to deficient oxygenation of
blood), rapid heart rate, unconsciousness and possible death. Effects
may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation.
Notes to Physician:
Treat symptomatically and supportively. For methemoglobinemia,
administer oxygen alone or with Methylene Blue depending on the
methemoglobin concentration in the blood.
Antidote:
Methylene blue, alone or in combination with oxygen is indicated as
a treatment in nitrite induced methemoglobinemia.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Will burn
if involved in a fire. Containers may explode in the heat of a fire.
Vapors may be heavier than air. They can spread along the ground
and collect in low or confined areas. Runoff from fire control or
dilution water may cause pollution.
Extinguishing Media:
Use water spray to cool fire-exposed containers. Use water spray,
dry chemical, carbon dioxide, or chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Provide
ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation. Use with adequate ventilation. Wash clothing before
reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Store
protected from moisture.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 142-26-7:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Viscous liquid
Color: pale yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 135 - 137 deg C @ 3mmHg
Freezing/Melting Point: 15.8 deg C
Autoignition Temperature: 460 deg C ( 860.00 deg F)
Flash Point: 176 deg C ( 348.80 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Soluble.
Specific Gravity/Density: 1.11
Molecular Formula: C4H9NO2
Molecular Weight: 103.12
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, light, excess heat, exposure to moist air or
water.
Incompatibilities with Other Materials:
Moisture, oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 142-26-7: AC3120000
LD50/LC50:
CAS# 142-26-7: Draize test, rabbit, eye: 500 mg Severe; Oral, rat:
LD50 = 26950 mg/kg; Skin, rabbit: LD50 = >20 mL/kg.
Carcinogenicity:
N-Acetylethanolamine -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 142-26-7: No information available.
Canada
CAS# 142-26-7 is listed on Canada's DSL List.
CAS# 142-26-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 142-26-7 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 2/03/2000 Revision #4 Date: 6/17/2002
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Barbituric Acid
| 67-52-7 |
|
3-Carboxypropyl triphenylphosphonium bromide, 97%
| 17857-14-6 |
|
Triphenylphosphine Hydroiodide
| 0-01-1 |
|
2-Amino-5-Nitrobenzoic Acid, 98%
| 616-79-5 |
|
Methyl 2,3-Dichlorobenzoate, 97%
| 2905-54-6 |
|
4-Bromobutyl triphenylphosphonium bromide, 97%
| 7333-63-3 |
|
4-Nitrobenzyl triphenylphosphonium bromide, 97%
| 2767-70-6 |
|
Cyanomethyl triphenylphosphonium chloride, 97%
| 4336-70-3 |
|
Triacontane, 98%
| 638-68-6 |
|
tert-Butoxycarbonylmethyl triphenylphosphonium bromide, 97%
| 59159-39-6 |
|
2,3,4,5,6-Pentabromobenzyl alcohol, 97%
| 79415-41-1 |
|
Acenaphthylene
| 208-96-8 |
|
5-Chlorothiophenesulphonyl chloride, 96%
| 2766-74-7 |
|
P-Bromophenoxyacetic Acid, 97%
| 1878-91-7 |
|
5-Bromothiophenesulphonyl chloride, 96%
| 55854-46-1 |
|
Methyl 5-Acetylsalicylate, 98%
| 16475-90-4 |
|
Barium acetate
| 543-80-6 |
|
Ibuprofen, 99%
| 15687-27-1 |
|
4,5-Dimethylthiophene-2-carboxaldehyde, 97%
| 0-01-1 |
|
(S)-1,2,4-Butanetriol, 95%, (99% e.e.)
| 42890-76-6 |
|
Ethyl (R)-4-cyano-3-hydroxybutanoate, 99%
| 141942-85-0 |
|
3-Methyl-2-furoic acid, 98%
| 4412-96-8 |
|
p-Acetaminobenzaldehyde, 97%
| 0-01-1 |
|
(S)-1,4-Dibromo-2-Butanol, 96%
| 64028-90-6 |
|
N,N'-Difluoro-2,2'-bipyridinium bis(tetrafluoroborate)
| 178439-26-4 |
|
4-Amino-6-methoxypyrimidine, 98%
| 0-01-1 |
|
Captopril, 98%
| 62571-86-2 |
|
Methyl (S)-(+)-3-Hydroxybutyrate, 99%
| 53562-86-0 |
|
2,5-Dimethoxybenzoic Acid, 98%
| 2785-98-0 |
|
Thallium (I) trifluoroacetylacetonate, 97%
| 54412-40-7 |
|
2-Methyl-2-Adamantanol, 98%
| 702-98-7 |
|
3-Noradmantanecarboxylic Acid, 98%
| 16200-53-6 |
|
Resorcin Blue
| 42249-61-6 |
|
Methylene violet 3RAX
| 4569-86-2 |
|
DL-allo-Threonine, 98%
| 0-01-1 |
|
1-Chloro-3,4-difluorobenzene, 99%
| 696-02-6 |
|
Methyl Red hydrochloride, reagent ACS
| 63451-28-5 |
|
Fast Sulphon Black F
| 3682-47-1 |
|
Methyl 5-nitro-2-furoate, 97%
| 1874-23-3 |
|
N-Aminohomopiperidine, 95%
| 5906-35-4 |
|
DOTAP mesylate
| 144139-73-1 |
|
Leishman stain
| 12627-53-1 |
|
1-Ethyl-2-iodobenzene, 98%
| 18282-40-1 |
|
Patent Blue V
| 3536-49-0 |
|
3-Methyl-1-penten-4-yn-3-ol, 99%
| 3230-69-1 |
|
Chelidamic Acid Monohydrate
| 138-60-3 |
|
N-Acetylethanolamine
| 142-26-7 |
|
Tetrahydrofuran-2,3,4,5-tetracarboxylic acid
| 26106-63-8 |
|
2,3,5,6-Tetramethyl-P-Phenylenediamine
| 3102-87-2 |
|
(S)-(+)-N-Alpha-Benzyl-N-Beta-BOC-L-Hydrazinoleucine
| 0-01-1 |
|
|